Lexaria Bioscience Corp Sustainability Reports
The company operates as a biotechnology enterprise focused on enhancing the oral delivery and bio-absorption of active pharmaceutical ingredients through its proprietary DehydraTECH drug delivery technology. It generates revenue primarily through licensing this technology to corporate customers.
Sector: Manufacturing
Country: Canada
Exchange: Nasdaq
11 reports from 2008 to 2025
Company Profile
The company operates as a biotechnology enterprise focused on enhancing the oral delivery and bio-absorption of active pharmaceutical ingredients through its proprietary DehydraTECH drug delivery technology. It generates revenue primarily through licensing this technology to corporate customers.
Reports
11 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
